爱尔眼科有增持和收购_老虎社区_美港股上老虎

2022-11-30

爱尔眼科有增持和收购利好，仍需板块和大盘配合

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":620281262,"tweetId":"620281262","gmtCreate":1669787827656,"gmtModify":1669787829527,"author":{"id":3461641694828268,"authorId":3461641694828268,"authorIdStr":"3461641694828268","name":"山林小竹","avatar":"https://static.tigerbbs.com/3d2e55120b5cfb573f7cfdcc1f4bb90b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>爱尔眼科有增持和收购利好，仍需板块和大盘配合</p></body></html>","htmlText":"<html><head></head><body><p>爱尔眼科有增持和收购利好，仍需板块和大盘配合</p></body></html>","text":"爱尔眼科有增持和收购利好，仍需板块和大盘配合","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/620281262","repostId":0,"isVote":1,"tweetType":1,"viewCount":898,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["300015"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":43,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/620281262"}